Non-narcotic Solution DyAnsys offers a non-narcotic chronic pain treatment solution, presenting a compelling sales angle to pain management distributors seeking to expand beyond narcotics.

U.S. Expansion The company is rapidly growing and actively seeks to expand coverage of the U.S. market, identifying a need for distributors with established pain management client bases and full territory coverage.

Medical Device Focus Target distributors with a background in medical device sales and distribution, preferably with access to a sizable sales force or 1099 reps to ensure rapid market reach.

Clinical Applications DyAnsys leverages ECG and electrical signal analysis for chronic and acute pain, anesthesia, diabetes, and fetal heart monitoring, suggesting multiple cross-sell opportunities across pain, monitoring, and diagnostics segments.

Competitive Positioning With a revenue range indicating a smaller but scalable platform and growth potential, emphasize rapid adoption by specialized pain management distributors to accelerate market share against peers in medical signal analysis and neuromodulation.